Searched over 200M research papers
10 papers analyzed
These studies suggest that dysplasia refers to abnormal cell growth and differentiation in various tissues, including the uterine cervix, gastrointestinal tract, and skeletal system, often indicating a precancerous condition or genetic disorder.
20 papers analyzed
Dysplasia is a medical term used to describe abnormal cellular development within tissues or organs. It is characterized by an increase in immature cells and abnormal differentiation, which can be a precursor to cancer. Dysplasia is often identified in epithelial tissues and is considered a neoplastic alteration without invasive growth, synonymous with intraepithelial neoplasia .
In the context of the uterine cervix, dysplasia involves heteroplastic lesions of the surface epithelium. These lesions show a relative or absolute increase in immature cells and abnormal differentiation. The severity of dysplasia can vary, with higher degrees approaching carcinoma in situ, necessitating more serious clinical consideration. The term has been used interchangeably with other terminologies such as atypia, atypical hyperplasia, and precancerous metaplasia, reflecting the varied histopathological changes observed.
In gastrointestinal pathology, dysplasia refers to non-invasive neoplastic epithelial changes and is a marker for high cancer risk. It is crucial to distinguish dysplasia from regenerative, inflammatory, and reactive changes due to their different clinical implications . Dysplasia in the gastrointestinal tract is often found in polypoid lesions, with flat mucosal dysplasia being less common.
Gastrointestinal dysplasia is classified into low-grade and high-grade lesions. However, distinguishing between regenerative epithelium and low-grade dysplasia, as well as between low-grade and high-grade dysplasia, can be challenging due to overlapping cytological features . The category "indefinite for dysplasia" is used when it is difficult to make a clear distinction, indicating the need for further biopsy and surveillance .
Skeletal dysplasias, also known as osteochondrodysplasias, are a group of over 350 genetic disorders affecting bone development, growth, and maintenance. These conditions often result in orthopedic complications and varying degrees of dwarfism or short stature . Diagnosis is based on radiographic, clinical, and molecular criteria, with recent advances linking specific genetic defects to these disorders .
Management of skeletal dysplasias involves preventing or minimizing medical complications, providing psychosocial support, and modifying the environment to improve the quality of life for affected individuals. A precise diagnosis is crucial for effective management and understanding familial recurrence .
Focal cortical dysplasia (FCD) refers to a range of cortical mantle alterations associated with epilepsy. It is classified into three subtypes based on neuropathological characteristics: architectural dysplasia, cytoarchitectural dysplasia, and Taylor-type cortical dysplasia. Each subtype has distinct clinical and neuroimaging features, influencing surgical outcomes and seizure management.
Dysplasia is a critical concept in medical pathology, representing abnormal cellular development that can precede cancer. Its implications vary across different tissues, from the uterine cervix and gastrointestinal tract to skeletal and cortical structures. Accurate diagnosis and classification are essential for effective clinical management and improving patient outcomes. Understanding the nuances of dysplasia in various contexts helps in early detection and appropriate therapeutic interventions.
Most relevant research papers on this topic